LOPERAMIDE HYDROCHLORIDE

LOPERAMIDE HYDROCHLORIDE was reported 45181 times

These side effects are most commonly reported by patients taking LOPERAMIDE HYDROCHLORIDE:

# Side effect Count
0 DIARRHOEA 9029
1 NAUSEA 4357
2 DRUG INEFFECTIVE 4117
3 FATIGUE 3949
4 OFF LABEL USE 3260
5 VOMITING 2818
6 CONSTIPATION 2541
7 WEIGHT DECREASED 2125
8 HEADACHE 2076
9 DYSPNOEA 2051
10 ASTHENIA 1867
11 DECREASED APPETITE 1847
12 ABDOMINAL PAIN 1846
13 DIZZINESS 1759
14 PAIN 1678
15 PNEUMONIA 1641
16 DEHYDRATION 1595
17 PYREXIA 1574
18 MALAISE 1487
19 INCORRECT DOSE ADMINISTERED 1360
20 COUGH 1356
21 DEATH 1352
22 ARTHRALGIA 1319
23 RASH 1229
24 ABDOMINAL PAIN UPPER 1218
25 INTENTIONAL PRODUCT USE ISSUE 1201
26 ANAEMIA 1140
27 FALL 1128
28 PAIN IN EXTREMITY 1081
29 ABDOMINAL DISCOMFORT 958
30 BACK PAIN 938
31 SOMNOLENCE 882
32 URINARY TRACT INFECTION 882
33 CONDITION AGGRAVATED 878
34 HYPOTENSION 878
35 PRURITUS 865
36 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 811
37 GASTROOESOPHAGEAL REFLUX DISEASE 804
38 INSOMNIA 799
39 ABDOMINAL DISTENSION 796
40 MUSCLE SPASMS 767
41 DYSPEPSIA 741
42 HYPERTENSION 738
43 OEDEMA PERIPHERAL 732
44 PERIPHERAL SWELLING 731
45 PRODUCT DOSE OMISSION ISSUE 724
46 BLOOD PRESSURE INCREASED 722
47 NASOPHARYNGITIS 714
48 ACUTE KIDNEY INJURY 712
49 FLATULENCE 711
50 OVERDOSE 687
51 PRODUCT USE IN UNAPPROVED INDICATION 681
52 WEIGHT INCREASED 676
53 CHEST PAIN 645
54 ANXIETY 643
55 FEELING ABNORMAL 627
56 EXPIRED PRODUCT ADMINISTERED 623
57 PRODUCT USE ISSUE 616
58 NEUTROPENIA 581
59 PLATELET COUNT DECREASED 579
60 INCORRECT PRODUCT ADMINISTRATION DURATION 578
61 SEPSIS 566
62 HAEMOGLOBIN DECREASED 565
63 ALOPECIA 564
64 WHITE BLOOD CELL COUNT DECREASED 557
65 HAEMATOCHEZIA 551
66 ERYTHEMA 534
67 GAIT DISTURBANCE 532
68 CONFUSIONAL STATE 521
69 FREQUENT BOWEL MOVEMENTS 518
70 HYPOKALAEMIA 517
71 COLITIS 516
72 CROHN^S DISEASE 516
73 COVID-19 512
74 DEPRESSION 505
75 GASTROINTESTINAL DISORDER 495
76 CHILLS 493
77 STOMATITIS 490
78 INFECTION 483
79 DYSPHAGIA 481
80 INTENTIONAL PRODUCT MISUSE 479
81 MALIGNANT NEOPLASM PROGRESSION 474
82 DISEASE PROGRESSION 468
83 NEUROPATHY PERIPHERAL 468
84 MYALGIA 463
85 RENAL FAILURE 462
86 DRY SKIN 457
87 HYPOAESTHESIA 456
88 OROPHARYNGEAL PAIN 456
89 COMA 451
90 SYNCOPE 450
91 THROMBOCYTOPENIA 450
92 BLOOD CREATININE INCREASED 438
93 FEBRILE NEUTROPENIA 437
94 ATRIAL FIBRILLATION 425
95 DRUG INTERACTION 418
96 HYPERSENSITIVITY 416
97 PNEUMONIA ASPIRATION 414
98 INFLUENZA 412
99 TREMOR 412
100 JOINT SWELLING 411
101 INTESTINAL OBSTRUCTION 408
102 ILLNESS 402
103 GENERAL PHYSICAL HEALTH DETERIORATION 401
104 DYSGEUSIA 396
105 PARAESTHESIA 396
106 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 396
107 EPISTAXIS 393
108 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 391
109 DRUG HYPERSENSITIVITY 390
110 WHEEZING 387
111 SINUSITIS 386
112 CHOLELITHIASIS 381
113 RECTAL HAEMORRHAGE 381
114 TOXICITY TO VARIOUS AGENTS 377
115 CONTUSION 376
116 DRUG ABUSE 376
117 LOSS OF CONSCIOUSNESS 374
118 PRODUCTIVE COUGH 373
119 COLITIS ULCERATIVE 370
120 PLEURAL EFFUSION 370
121 INJECTION SITE PAIN 367
122 DRY MOUTH 359
123 HEPATIC ENZYME INCREASED 356
124 PULMONARY EMBOLISM 347
125 RHINORRHOEA 345
126 MEMORY IMPAIRMENT 342
127 MUSCULAR WEAKNESS 342
128 BLOOD POTASSIUM DECREASED 341
129 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 338
130 PRODUCT PACKAGING ISSUE 334
131 BLOOD GLUCOSE INCREASED 327
132 HEART RATE INCREASED 318
133 CEREBROVASCULAR ACCIDENT 317
134 MACULAR DEGENERATION 317
135 URTICARIA 317
136 CHEST DISCOMFORT 312
137 HYPONATRAEMIA 310
138 FLUSHING 309
139 FAECES DISCOLOURED 308
140 HOSPITALISATION 307
141 UNDERDOSE 307
142 INFUSION RELATED REACTION 305
143 BRONCHITIS 304
144 DYSPNOEA EXERTIONAL 304
145 OXYGEN SATURATION DECREASED 299
146 TACHYCARDIA 299
147 CARDIAC ARREST 297
148 HYPERHIDROSIS 297
149 HOT FLUSH 296
150 PALPITATIONS 294
151 VISION BLURRED 294
152 BLOOD BILIRUBIN INCREASED 285
153 BLOOD PRESSURE SYSTOLIC INCREASED 283
154 DYSPHONIA 283
155 GASTROINTESTINAL HAEMORRHAGE 282
156 DRUG INTOLERANCE 281
157 VISUAL IMPAIRMENT 278
158 RENAL IMPAIRMENT 277
159 BALANCE DISORDER 275
160 ELECTROCARDIOGRAM QT PROLONGED 275
161 FLUID RETENTION 268
162 SCHIZOPHRENIA 266
163 THROMBOSIS 264
164 STRESS 263
165 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 262
166 SLEEP DISORDER 262
167 BLOOD PRESSURE DECREASED 261
168 NASAL CONGESTION 258
169 OEDEMA 257
170 OSTEOARTHRITIS 249
171 BLISTER 247
172 SWELLING 247
173 MYOCARDIAL INFARCTION 244
174 ARTHRITIS 241
175 RED BLOOD CELL COUNT DECREASED 236
176 MIGRAINE 235
177 PANCYTOPENIA 235
178 SMALL INTESTINAL OBSTRUCTION 234
179 CELLULITIS 233
180 INCORRECT DRUG ADMINISTRATION DURATION 231
181 PAIN IN JAW 230
182 SEIZURE 230
183 RESPIRATORY FAILURE 229
184 THERAPY NON-RESPONDER 227
185 NEUTROPHIL COUNT DECREASED 224
186 HAEMORRHAGE 223
187 ASPARTATE AMINOTRANSFERASE INCREASED 222
188 CATARACT 221
189 ORAL PAIN 221
190 CARDIAC DISORDER 218
191 VERTIGO 216
192 BONE PAIN 215
193 DRY EYE 214
194 MUSCULOSKELETAL STIFFNESS 214
195 DEEP VEIN THROMBOSIS 209
196 LETHARGY 209
197 TASTE DISORDER 209
198 MUCOSAL INFLAMMATION 207
199 THROAT IRRITATION 207
200 CHRONIC KIDNEY DISEASE 204
201 HAEMORRHOIDS 204
202 PROCEDURAL PAIN 204
203 RASH PRURITIC 203
204 SEPTIC SHOCK 203
205 HEPATOTOXICITY 202
206 HYPOMAGNESAEMIA 202
207 CLOSTRIDIUM DIFFICILE INFECTION 201
208 NEPHROLITHIASIS 201
209 ALANINE AMINOTRANSFERASE INCREASED 199
210 ASCITES 199
211 CARDIAC FAILURE 199
212 RENAL FAILURE ACUTE 198
213 RETCHING 196
214 SKIN EXFOLIATION 196
215 ASTHMA 195
216 CARDIAC FAILURE CONGESTIVE 195
217 NECK PAIN 195
218 PSYCHOTIC DISORDER 194
219 BURNING SENSATION 192
220 PANCREATITIS 190
221 ADVERSE DRUG REACTION 189
222 DRUG DOSE OMISSION 188
223 MOBILITY DECREASED 188
224 HERPES ZOSTER 186
225 HYPOXIA 186
226 ORAL CANDIDIASIS 185
227 HEART RATE DECREASED 184
228 HYPOMANIA 184
229 PNEUMONITIS 184
230 DYSURIA 183
231 THERAPEUTIC RESPONSE UNEXPECTED 182
232 UPPER RESPIRATORY TRACT INFECTION 181
233 JAUNDICE CHOLESTATIC 180
234 INTENTIONAL OVERDOSE 179
235 HAEMATOCRIT DECREASED 176
236 IRRITABLE BOWEL SYNDROME 176
237 LEUKOPENIA 176
238 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 176
239 PRODUCT USE COMPLAINT 176
240 INFLUENZA LIKE ILLNESS 175
241 NIGHT SWEATS 175
242 PARAESTHESIA ORAL 173
243 C-REACTIVE PROTEIN INCREASED 172
244 ADVERSE EVENT 171
245 CHRONIC SINUSITIS 170
246 DIABETES MELLITUS 169
247 RHEUMATOID ARTHRITIS 169
248 DISCOMFORT 165
249 VENTRICULAR TACHYCARDIA 165
250 UNEVALUABLE EVENT 164
251 ANAL INCONTINENCE 162
252 LOWER RESPIRATORY TRACT INFECTION 159
253 WHITE BLOOD CELL COUNT INCREASED 159
254 FEELING COLD 157
255 SKIN LESION 154
256 SWELLING FACE 154
257 LYMPHADENOPATHY 152
258 SEASONAL ALLERGY 152
259 TORSADE DE POINTES 152
260 POLLAKIURIA 151
261 HYPERGLYCAEMIA 150
262 MUSCULOSKELETAL CHEST PAIN 150
263 PLASMA CELL MYELOMA 150
264 DEPRESSED MOOD 149
265 INTERSTITIAL LUNG DISEASE 149
266 RENAL DISORDER 149
267 LUNG DISORDER 148
268 DIVERTICULITIS 147
269 BLOOD MAGNESIUM DECREASED 146
270 HYPOCALCAEMIA 145
271 LUNG NEOPLASM MALIGNANT 145
272 AMNESIA 144
273 FEELING HOT 144
274 LIMB DISCOMFORT 144
275 SKIN DISCOLOURATION 144
276 BRADYCARDIA 143
277 HALLUCINATION 143
278 PRODUCT PACKAGE ASSOCIATED INJURY 143
279 ARTHROPATHY 142
280 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 141
281 BLOOD SODIUM DECREASED 140
282 PRODUCT PACKAGING DIFFICULT TO OPEN 140
283 PULMONARY OEDEMA 139
284 HYPOTHYROIDISM 138
285 INFUSION SITE PAIN 138
286 NERVOUSNESS 138
287 VASCULAR DEVICE INFECTION 137
288 CARDIAC MURMUR 136
289 HYPOPHAGIA 136
290 URINARY RETENTION 136
291 GASTRITIS 135
292 ACNE 134
293 CYSTITIS 134
294 DRUG DEPENDENCE 134
295 PROCTITIS 134
296 ABDOMINAL PAIN LOWER 133
297 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 133
298 INFLAMMATION 132
299 MUSCULOSKELETAL PAIN 132
300 RHINITIS ALLERGIC 132
301 AGEUSIA 131
302 ARRHYTHMIA 131
303 BLOOD PRESSURE FLUCTUATION 130
304 GAMMA-GLUTAMYLTRANSFERASE INCREASED 130
305 FEMALE GENITAL TRACT FISTULA 129
306 VIRAL INFECTION 128
307 ACCIDENTAL OVERDOSE 127
308 BLOOD ALKALINE PHOSPHATASE INCREASED 127
309 HIP FRACTURE 127
310 INJECTION SITE ERYTHEMA 127
311 HYPERKALAEMIA 125
312 WRONG TECHNIQUE IN DRUG USAGE PROCESS 125
313 BRONCHIECTASIS 124
314 THERAPEUTIC RESPONSE DECREASED 124
315 DEFAECATION URGENCY 123
316 AGITATION 122
317 LABORATORY TEST ABNORMAL 122
318 OSTEOPENIA 122
319 TREATMENT FAILURE 122
320 ABNORMAL FAECES 121
321 BLOOD PRESSURE DIASTOLIC DECREASED 121
322 DISORIENTATION 121
323 NEOPLASM PROGRESSION 121
324 RASH ERYTHEMATOUS 121
325 TOTAL LUNG CAPACITY INCREASED 121
326 FAECES SOFT 120
327 FISTULA 120
328 VAGINAL DISCHARGE 120
329 MALNUTRITION 119
330 PRESYNCOPE 119
331 DRUG EFFECT DECREASED 118
332 FEEDING DISORDER 118
333 GASTROENTERITIS 118
334 LIVER DISORDER 118
335 SKIN DISORDER 118
336 BLOOD POTASSIUM INCREASED 117
337 IMPAIRED HEALING 117
338 RADICULOPATHY 117
339 OSTEOPOROSIS 116
340 PRODUCT DOSE OMISSION 116
341 SKIN ULCER 116
342 CHROMATURIA 115
343 SKIN FISSURES 115
344 STAPHYLOCOCCAL INFECTION 115
345 BLOOD IRON DECREASED 114
346 COLITIS MICROSCOPIC 114
347 PRODUCT QUALITY ISSUE 114
348 PULMONARY HYPERTENSION 114
349 INJURY 113
350 ELECTROLYTE IMBALANCE 112
351 MENTAL STATUS CHANGES 112
352 VAGINAL FLATULENCE 112
353 CLOSTRIDIUM DIFFICILE COLITIS 111
354 LIVER FUNCTION TEST ABNORMAL 111
355 MOVEMENT DISORDER 111
356 NEOPLASM MALIGNANT 111
357 TREATMENT NONCOMPLIANCE 111
358 GASTROINTESTINAL PAIN 110
359 PANCREATITIS ACUTE 110
360 SARCOIDOSIS 110
361 EAR PAIN 109
362 EMOTIONAL DISTRESS 109
363 ILEUS 109
364 PERICARDIAL EFFUSION 109
365 FULL BLOOD COUNT DECREASED 108
366 INTERNATIONAL NORMALISED RATIO INCREASED 108
367 METABOLIC ACIDOSIS 108
368 RASH MACULAR 108
369 HYPERSOMNIA 107
370 NASAL POLYPS 107
371 SPEECH DISORDER 107
372 SUICIDE ATTEMPT 107
373 ERUCTATION 106
374 FUNGAL INFECTION 106
375 TOXIC EPIDERMAL NECROLYSIS 106
376 HEPATIC FUNCTION ABNORMAL 105
377 NO ADVERSE EVENT 104
378 RESPIRATORY TRACT INFECTION 104
379 SURGERY 104
380 TRANSIENT ISCHAEMIC ATTACK 103
381 ANAPHYLACTIC REACTION 102
382 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 102
383 DEVICE ISSUE 102
384 GASTRIC DISORDER 102
385 PSORIASIS 102
386 ACUTE RESPIRATORY FAILURE 101
387 MENTAL DISORDER 101
388 POOR QUALITY SLEEP 101
389 THERAPY INTERRUPTED 101
390 URINARY INCONTINENCE 101
391 WEIGHT FLUCTUATION 101
392 BACTERIAL INFECTION 100
393 CYST 100
394 DISTURBANCE IN ATTENTION 100
395 EYE PAIN 100
396 BLOOD GLUCOSE DECREASED 99
397 BLOOD UREA INCREASED 99
398 EATING DISORDER 99
399 HAEMATURIA 99
400 ORAL DISCOMFORT 99
401 OSTEOMYELITIS 99
402 TOOTH DISORDER 99
403 BOWEL MOVEMENT IRREGULARITY 98
404 GASTROENTERITIS VIRAL 98
405 HYPOGLYCAEMIA 98
406 LIMB INJURY 98
407 PALLOR 98
408 RIB FRACTURE 98
409 APPETITE DISORDER 97
410 BLOOD CALCIUM DECREASED 97
411 CHOKING 97
412 DEVICE RELATED INFECTION 97
413 HAIR COLOUR CHANGES 96
414 TINNITUS 96
415 COGNITIVE DISORDER 95
416 HEPATIC FAILURE 95
417 DYSARTHRIA 94
418 INTERVERTEBRAL DISC PROTRUSION 94
419 HAEMOPTYSIS 93
420 INJECTION SITE BRUISING 93
421 JAUNDICE 93
422 ILL-DEFINED DISORDER 92
423 METASTASES TO LIVER 92
424 TENDERNESS 92
425 THERAPEUTIC PRODUCT EFFECT DECREASED 92
426 ROAD TRAFFIC ACCIDENT 91
427 ENCEPHALOPATHY 90
428 EPILEPSY 90
429 INFUSION SITE ERYTHEMA 90
430 PRODUCT SIZE ISSUE 90
431 BODY TEMPERATURE DECREASED 89
432 DERMATITIS CONTACT 89
433 GLOSSODYNIA 89
434 LEUKOCYTOSIS 89
435 WOUND 89
436 CROHN'S DISEASE 88
437 DELIRIUM 88
438 HEPATIC STEATOSIS 88
439 INTENTIONAL SELF-INJURY 88
440 IRRITABILITY 88
441 LACRIMATION INCREASED 87
442 MOUTH ULCERATION 87
443 PRODUCT DOSE OMISSION IN ERROR 87
444 CARDIO-RESPIRATORY ARREST 86
445 SKIN CANCER 86
446 GASTRIC ULCER 85
447 SUICIDAL IDEATION 85
448 BLOOD PRESSURE ABNORMAL 84
449 HYPOACUSIS 84
450 INTESTINAL PERFORATION 84
451 LARGE INTESTINE POLYP 84
452 ANAL FISSURE 83
453 EJECTION FRACTION DECREASED 83
454 HEAD INJURY 83
455 ENTERITIS 82
456 LOCALISED INFECTION 82
457 LYMPHOCYTE COUNT DECREASED 82
458 SINUS DISORDER 82
459 ANTICHOLINERGIC SYNDROME 81
460 APHASIA 81
461 DIARRHOEA HAEMORRHAGIC 81
462 DRUG WITHDRAWAL SYNDROME 81
463 GASTROINTESTINAL SOUNDS ABNORMAL 81
464 HEART RATE IRREGULAR 81
465 HERNIA 81
466 NEOPLASM 81
467 PROCTALGIA 81
468 RALES 81
469 RASH MACULO-PAPULAR 81
470 BLOOD CHOLESTEROL INCREASED 80
471 BRAIN FOG 80
472 DRUG ADMINISTRATION ERROR 80
473 GOUT 80
474 HAEMATEMESIS 80
475 PRODUCT TASTE ABNORMAL 80
476 UPPER LIMB FRACTURE 80
477 BODY TEMPERATURE INCREASED 79
478 ENTEROCOLITIS 79
479 GALLBLADDER DISORDER 79
480 PNEUMOTHORAX 79
481 ATELECTASIS 78
482 END STAGE RENAL DISEASE 78
483 EPIGASTRIC DISCOMFORT 78
484 MEDICATION ERROR 78
485 DEPRESSED LEVEL OF CONSCIOUSNESS 77
486 ECZEMA 77
487 INJECTION SITE HAEMORRHAGE 77
488 PRODUCT BLISTER PACKAGING ISSUE 77
489 RESPIRATORY DISTRESS 77
490 ANGINA PECTORIS 76
491 FAECALOMA 76
492 OBSTRUCTIVE AIRWAYS DISORDER 76
493 PANIC ATTACK 76
494 POST PROCEDURAL COMPLICATION 76
495 GLYCOSYLATED HAEMOGLOBIN INCREASED 75
496 SNEEZING 75
497 THERAPEUTIC REACTION TIME DECREASED 75
498 ABSCESS 74
499 BLOOD URINE PRESENT 74
500 EXPOSURE DURING PREGNANCY 74
501 POOR VENOUS ACCESS 74
502 DYSSTASIA 73
503 HYPOPHOSPHATAEMIA 73
504 MUSCULOSKELETAL DISCOMFORT 73
505 THERAPY PARTIAL RESPONDER 73
506 THIRST 73
507 DIZZINESS POSTURAL 72
508 ONYCHOCLASIS 72
509 PHOTOPHOBIA 72
510 WITHDRAWAL SYNDROME 72
511 CHOLESTASIS 71
512 HIATUS HERNIA 71
513 INFREQUENT BOWEL MOVEMENTS 71
514 IRON DEFICIENCY ANAEMIA 71
515 LIVER FUNCTION TEST INCREASED 71
516 BLOOD TEST ABNORMAL 70
517 JOINT INJURY 70
518 PULMONARY ARTERIAL HYPERTENSION 70
519 CONTRAINDICATED PRODUCT ADMINISTERED 69
520 ARTERIOSCLEROSIS CORONARY ARTERY 68
521 DECUBITUS ULCER 68
522 EAR INFECTION 68
523 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 68
524 METASTASES TO LUNG 68
525 SPLENOMEGALY 68
526 HEPATITIS 67
527 OESOPHAGITIS 67
528 PRODUCT LABEL ISSUE 67
529 SPUTUM DISCOLOURED 67
530 BASAL CELL CARCINOMA 66
531 DEVICE MALFUNCTION 66
532 DYSKINESIA 66
533 GASTROINTESTINAL INFECTION 66
534 GINGIVAL BLEEDING 66
535 INFUSION SITE SWELLING 66
536 NERVOUS SYSTEM DISORDER 66
537 NEURALGIA 66
538 AGGRESSION 65
539 ANOREXIA 65
540 BACTERAEMIA 65
541 INJECTION SITE PRURITUS 65
542 KIDNEY INFECTION 65
543 MUCOUS STOOLS 65
544 ORTHOSTATIC HYPOTENSION 65
545 RESPIRATORY DISORDER 65
546 RESTLESSNESS 65
547 SHOCK 65
548 SWOLLEN TONGUE 65
549 ACUTE MYOCARDIAL INFARCTION 64
550 BLOOD PRESSURE DIASTOLIC ABNORMAL 64
551 DEMENTIA 64
552 EYE DISORDER 64
553 INCONTINENCE 64
554 INCREASED APPETITE 64
555 RESPIRATORY TRACT CONGESTION 64
556 COLON CANCER 63
557 GASTROINTESTINAL MOTILITY DISORDER 63
558 PLEURAL FIBROSIS 63
559 BLOOD COUNT ABNORMAL 62
560 BLOOD PRESSURE DIASTOLIC INCREASED 62
561 BREAST CANCER 62
562 DEAFNESS NEUROSENSORY 62
563 FAILURE TO THRIVE 62
564 FIBROMYALGIA 62
565 FLANK PAIN 62
566 GASTROINTESTINAL STOMA COMPLICATION 62
567 HYPOALBUMINAEMIA 62
568 HYPOVOLAEMIA 62
569 PULMONARY THROMBOSIS 62
570 RHABDOMYOLYSIS 62
571 SCIATICA 62
572 THERAPY CESSATION 62
573 UNRESPONSIVE TO STIMULI 62
574 UROSEPSIS 62
575 ABNORMAL BEHAVIOUR 61
576 BLOOD LACTATE DEHYDROGENASE INCREASED 61
577 DRUG EFFECT INCOMPLETE 61
578 HAEMATOMA 61
579 MUSCLE STRAIN 61
580 PRODUCT PHYSICAL ISSUE 61
581 PRODUCT PRESCRIBING ERROR 61
582 STEVENS-JOHNSON SYNDROME 61
583 TOOTH INFECTION 61
584 ULCER 61
585 VENTRICULAR FIBRILLATION 61
586 DIPLOPIA 60
587 FULL BLOOD COUNT ABNORMAL 60
588 INTENTIONAL DOSE OMISSION 60
589 MASS 60
590 TOOTHACHE 60
591 ANAL FISTULA 59
592 DRUG EFFECT LESS THAN EXPECTED 59
593 DRUG LEVEL DECREASED 59
594 LUNG INFECTION 59
595 METASTASES TO BONE 59
596 PROTEINURIA 59
597 RENAL INJURY 59
598 ACCIDENTAL EXPOSURE TO PRODUCT 58
599 CANDIDA INFECTION 58
600 CONJUNCTIVITIS 58
601 DEVICE DISLOCATION 58
602 EXTRA DOSE ADMINISTERED 58
603 INJECTION SITE SWELLING 58
604 LIGAMENT SPRAIN 58
605 METASTASES TO CENTRAL NERVOUS SYSTEM 58
606 WRIST FRACTURE 58
607 ADRENAL INSUFFICIENCY 57
608 BLOOD ALBUMIN DECREASED 57
609 BLOOD PRESSURE SYSTOLIC ABNORMAL 57
610 CHOLECYSTITIS 57
611 EYE SWELLING 57
612 HYDRONEPHROSIS 57
613 PRODUCT ADMINISTRATION ERROR 57
614 PRODUCT STORAGE ERROR 57
615 SLEEP APNOEA SYNDROME 57
616 DERMATITIS ACNEIFORM 56
617 EYE IRRITATION 56
618 GAIT INABILITY 56
619 HEPATIC CIRRHOSIS 56
620 INJECTION SITE REACTION 56
621 LIP SWELLING 56
622 MULTI-ORGAN FAILURE 56
623 MULTIPLE ORGAN DYSFUNCTION SYNDROME 56
624 OCULAR HYPERAEMIA 56
625 OSTEONECROSIS OF JAW 56
626 PAIN OF SKIN 56
627 PERITONITIS 56
628 PRESBYACUSIS 56
629 SINUS CONGESTION 56
630 SUPRAVENTRICULAR TACHYCARDIA 56
631 UPPER GASTROINTESTINAL HAEMORRHAGE 56
632 ANGER 55
633 CARDIOMEGALY 55
634 FAECES HARD 55
635 GLAUCOMA 55
636 HUNGER 55
637 NOCTURIA 55
638 PULMONARY MASS 55
639 RASH PAPULAR 55
640 RENAL PAIN 55
641 RESTLESS LEGS SYNDROME 55
642 THYROID DISORDER 55
643 ANHEDONIA 54
644 APHONIA 54
645 CARDIOTOXICITY 54
646 EYE PRURITUS 54
647 HEPATIC NEOPLASM 54
648 MULTIPLE ALLERGIES 54
649 RIGHT VENTRICULAR FAILURE 54
650 SKIN LACERATION 54
651 APHTHOUS ULCER 53
652 BRAIN INJURY 53
653 HYPERTHYROIDISM 53
654 MULTIPLE SCLEROSIS RELAPSE 53
655 PHOTOSENSITIVITY REACTION 53
656 SKIN INFECTION 53
657 SPINAL OSTEOARTHRITIS 53
658 TYPE 2 DIABETES MELLITUS 53
659 ANORECTAL DISCOMFORT 52
660 CONVULSION 52
661 DEAFNESS 52
662 DIVERTICULUM 52
663 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 52
664 DRUG LEVEL INCREASED 52
665 INFLAMMATORY BOWEL DISEASE 52
666 ISCHAEMIC STROKE 52
667 JOINT STIFFNESS 52
668 MULTIPLE SCLEROSIS 52
669 PHARYNGITIS STREPTOCOCCAL 52
670 PLATELET COUNT INCREASED 52
671 SKIN IRRITATION 52
672 BLOOD MAGNESIUM INCREASED 51
673 COAGULOPATHY 51
674 CYTOMEGALOVIRUS INFECTION 51
675 DRY THROAT 51
676 FOOT FRACTURE 51
677 IMPAIRED QUALITY OF LIFE 51
678 LACTIC ACIDOSIS 51
679 NEPHROGENIC ANAEMIA 51
680 OBSTRUCTION 51
681 PULMONARY FIBROSIS 51
682 SPINAL FRACTURE 51
683 BLOOD TRIGLYCERIDES INCREASED 50
684 CORONARY ARTERY DISEASE 50
685 GASTROINTESTINAL STOMA OUTPUT INCREASED 50
686 GENERALISED OEDEMA 50
687 GENERALISED TONIC-CLONIC SEIZURE 50
688 HOSPICE CARE 50
689 LARGE INTESTINE PERFORATION 50
690 NAIL DISORDER 50
691 ORAL HERPES 50
692 THINKING ABNORMAL 50
693 TRANSFUSION 50
694 CYTOKINE RELEASE SYNDROME 49
695 DISEASE RECURRENCE 49
696 HAEMOGLOBIN INCREASED 49
697 HEAD DISCOMFORT 49
698 HYPERVOLAEMIA 49
699 INCREASED TENDENCY TO BRUISE 49
700 BONE MARROW FAILURE 48
701 BREAST CANCER METASTATIC 48
702 CEREBRAL HAEMORRHAGE 48
703 CYANOSIS 48
704 DEVICE OCCLUSION 48
705 DRUG PRESCRIBING ERROR 48
706 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 48
707 INFUSION SITE HAEMORRHAGE 48
708 LIPASE INCREASED 48
709 CRYING 47
710 GASTROINTESTINAL INFLAMMATION 47
711 HYPOAESTHESIA ORAL 47
712 LUNG INFILTRATION 47
713 MOOD ALTERED 47
714 POLYP 47
715 PRESCRIBED OVERDOSE 47
716 PRESCRIBED UNDERDOSE 47
717 PULMONARY CONGESTION 47
718 RESPIRATION ABNORMAL 47
719 RESPIRATORY DEPRESSION 47
720 THERAPEUTIC RESPONSE SHORTENED 47
721 ABORTION SPONTANEOUS 46
722 ASPIRATION 46
723 COMPLICATION ASSOCIATED WITH DEVICE 46
724 DECREASED IMMUNE RESPONSIVENESS 46
725 DERMATITIS 46
726 GRIP STRENGTH DECREASED 46
727 HAIR TEXTURE ABNORMAL 46
728 IMMUNODEFICIENCY 46
729 INSURANCE ISSUE 46
730 LYMPHOPENIA 46
731 RESPIRATORY ARREST 46
732 RHINOVIRUS INFECTION 46
733 SCAR 46
734 SKIN WARM 46
735 TOXIC SKIN ERUPTION 46
736 URINE OUTPUT DECREASED 46
737 VITAMIN D DECREASED 46
738 WOUND INFECTION 46
739 ALTERED STATE OF CONSCIOUSNESS 45
740 ATRIAL FLUTTER 45
741 FLUID OVERLOAD 45
742 IMPAIRED GASTRIC EMPTYING 45
743 PRODUCT AVAILABILITY ISSUE 45
744 PRODUCT DISTRIBUTION ISSUE 45
745 PROSTATE CANCER 45
746 SECRETION DISCHARGE 45
747 TRANSAMINASES INCREASED 45
748 AGRANULOCYTOSIS 44
749 ANAL ABSCESS 44
750 FRUSTRATION TOLERANCE DECREASED 44
751 HEPATIC LESION 44
752 HYPERBILIRUBINAEMIA 44
753 IMMUNE-MEDIATED ENTEROCOLITIS 44
754 MELAENA 44
755 MUSCLE TIGHTNESS 44
756 PLEURAL THICKENING 44
757 SENSITIVE SKIN 44
758 ANGIOEDEMA 43
759 DEVICE LEAKAGE 43
760 EMOTIONAL DISORDER 43
761 ESCHERICHIA INFECTION 43
762 EXOSTOSIS 43
763 LIVER INJURY 43
764 LUNG NEOPLASM 43
765 MENTAL IMPAIRMENT 43
766 PNEUMONIA BACTERIAL 43
767 POLYNEUROPATHY 43
768 RASH GENERALISED 43
769 SJOGREN^S SYNDROME 43
770 SQUAMOUS CELL CARCINOMA 43
771 ANAPHYLACTIC SHOCK 42
772 BODY HEIGHT DECREASED 42
773 CATHETER SITE ERYTHEMA 42
774 CHOLECYSTITIS ACUTE 42
775 DEVICE INFUSION ISSUE 42
776 DUODENAL ULCER 42
777 FACE OEDEMA 42
778 FAECAL CALPROTECTIN INCREASED 42
779 LYMPHOEDEMA 42
780 PERIPHERAL COLDNESS 42
781 RENAL FAILURE CHRONIC 42
782 SPINAL CORD COMPRESSION 42
783 THROAT TIGHTNESS 42
784 TOOTH ABSCESS 42
785 ACTIVITIES OF DAILY LIVING IMPAIRED 41
786 BLINDNESS 41
787 BLOOD MERCURY ABNORMAL 41
788 BONE DISORDER 41
789 DRUG-INDUCED LIVER INJURY 41
790 FEMUR FRACTURE 41
791 HAEMORRHOIDAL HAEMORRHAGE 41
792 HICCUPS 41
793 IDIOPATHIC PULMONARY FIBROSIS 41
794 INTESTINAL ISCHAEMIA 41
795 LOW DENSITY LIPOPROTEIN DECREASED 41
796 NEEDLE ISSUE 41
797 NODULE 41
798 SINUS TACHYCARDIA 41
799 ABASIA 40
800 BRONCHIAL SECRETION RETENTION 40
801 COLITIS ISCHAEMIC 40
802 FEELING JITTERY 40
803 HYPERCALCAEMIA 40
804 HYPERLIPIDAEMIA 40
805 MITRAL VALVE INCOMPETENCE 40
806 PRODUCT ADMINISTRATION INTERRUPTED 40
807 QUALITY OF LIFE DECREASED 40
808 CARDIOGENIC SHOCK 39
809 COVID-19 PNEUMONIA 39
810 DENTAL CARIES 39
811 DIABETES MELLITUS INADEQUATE CONTROL 39
812 ECONOMIC PROBLEM 39
813 HEMIPARESIS 39
814 ILEUS PARALYTIC 39
815 IMMUNOSUPPRESSION 39
816 LARGE INTESTINAL ULCER 39
817 LOWER GASTROINTESTINAL HAEMORRHAGE 39
818 NIGHTMARE 39
819 ORAL MUCOSAL BLISTERING 39
820 OSTEONECROSIS 39
821 OXYGEN CONSUMPTION INCREASED 39
822 SECOND PRIMARY MALIGNANCY 39
823 TONGUE DISCOMFORT 39
824 UVEITIS 39
825 VENTRICULAR EXTRASYSTOLES 39
826 YELLOW SKIN 39
827 CARPAL TUNNEL SYNDROME 38
828 COLECTOMY 38
829 DEVICE FAILURE 38
830 EXPOSURE TO TOXIC AGENT 38
831 GASTROINTESTINAL PROCEDURAL COMPLICATION 38
832 HYPERKERATOSIS 38
833 HYPERPARATHYROIDISM SECONDARY 38
834 IMMUNE SYSTEM DISORDER 38
835 INTESTINAL STENOSIS 38
836 LOCAL SWELLING 38
837 MIDDLE INSOMNIA 38
838 PERIPHERAL SENSORY NEUROPATHY 38
839 PRODUCT DIFFICULT TO SWALLOW 38
840 SKIN BURNING SENSATION 38
841 TACHYPNOEA 38
842 TUMOUR PAIN 38
843 VITAMIN D DEFICIENCY 38
844 ABDOMINAL ABSCESS 37
845 ABSCESS INTESTINAL 37
846 ARTHRITIS INFECTIVE 37
847 BRAIN OEDEMA 37
848 CHOLANGITIS 37
849 COLD SWEAT 37
850 COMPLETED SUICIDE 37
851 DRUG LEVEL BELOW THERAPEUTIC 37
852 DYSPHORIA 37
853 EMPHYSEMA 37
854 GASTROINTESTINAL OBSTRUCTION 37
855 HAEMORRHAGIC DIATHESIS 37
856 HEPATOMEGALY 37
857 INTERVERTEBRAL DISC DEGENERATION 37
858 MOUTH HAEMORRHAGE 37
859 PRODUCT SUBSTITUTION ISSUE 37
860 RETINAL DETACHMENT 37
861 THERAPEUTIC PRODUCT EFFECT VARIABLE 37
862 TOOTH FRACTURE 37
863 TRICUSPID VALVE INCOMPETENCE 37
864 ABDOMINAL ADHESIONS 36
865 APPENDICITIS 36
866 CARDIOMYOPATHY 36
867 DECREASED ACTIVITY 36
868 DRUG LEVEL ABOVE THERAPEUTIC 36
869 EMBOLISM 36
870 EYE HAEMORRHAGE 36
871 FOETAL EXPOSURE DURING PREGNANCY 36
872 MYELODYSPLASTIC SYNDROME 36
873 ORAL DISORDER 36
874 PELVIC FRACTURE 36
875 RESPIRATORY RATE INCREASED 36
876 VISUAL ACUITY REDUCED 36
877 BACTERIAL DISEASE CARRIER 35
878 BEDRIDDEN 35
879 BRONCHIAL WALL THICKENING 35
880 COORDINATION ABNORMAL 35
881 CYTOPENIA 35
882 DIABETIC KETOACIDOSIS 35
883 EOSINOPHILIA 35
884 FAECAL INCONTINENCE 35
885 FOOD ALLERGY 35
886 HAIR GROWTH ABNORMAL 35
887 HEPATIC CYTOLYSIS 35
888 MATERNAL EXPOSURE DURING PREGNANCY 35
889 NASAL DRYNESS 35
890 OSTEOSCLEROSIS 35
891 PARONYCHIA 35
892 PSEUDOMONAS INFECTION 35
893 STOMA COMPLICATION 35
894 SUDDEN DEATH 35
895 TEMPERATURE INTOLERANCE 35
896 VAGINAL HAEMORRHAGE 35
897 DRUG USE DISORDER 34
898 FOOD POISONING 34
899 HEPATOCELLULAR INJURY 34
900 IMPAIRED WORK ABILITY 34
901 INFUSION SITE INFECTION 34
902 JOINT DISLOCATION 34
903 LARYNGITIS 34
904 NEUTROPHIL COUNT ABNORMAL 34
905 POST PROCEDURAL HAEMORRHAGE 34
906 PRODUCT PRESCRIBING ISSUE 34
907 PROTEIN TOTAL DECREASED 34
908 SLUGGISHNESS 34
909 THERAPEUTIC RESPONSE DELAYED 34
910 UPPER-AIRWAY COUGH SYNDROME 34
911 VENTRICULAR ARRHYTHMIA 34
912 ABDOMINAL HERNIA 33
913 ACIDOSIS 33
914 BLOOD CREATINE PHOSPHOKINASE INCREASED 33
915 BONE DENSITY DECREASED 33
916 BRAIN NEOPLASM 33
917 CIRCULATORY COLLAPSE 33
918 EYE INFECTION 33
919 FLUID INTAKE REDUCED 33
920 FOREIGN BODY 33
921 LEFT VENTRICULAR DYSFUNCTION 33
922 LOCALISED OEDEMA 33
923 MALIGNANT MELANOMA 33
924 MYDRIASIS 33
925 NON-SMALL CELL LUNG CANCER 33
926 PANCREATIC CARCINOMA 33
927 PNEUMOCYSTIS JIROVECII PNEUMONIA 33
928 POST PROCEDURAL INFECTION 33
929 PYELONEPHRITIS 33
930 RENAL CYST 33
931 ROTATOR CUFF SYNDROME 33
932 SARS-COV-2 TEST POSITIVE 33
933 SKIN REACTION 33
934 TROPONIN INCREASED 33
935 ACUTE RESPIRATORY DISTRESS SYNDROME 32
936 ATAXIA 32
937 CHOLECYSTECTOMY 32
938 DEVICE USE ERROR 32
939 ELECTROCARDIOGRAM ABNORMAL 32
940 FOLLICULITIS 32
941 GLOMERULAR FILTRATION RATE DECREASED 32
942 INFUSION SITE DISCHARGE 32
943 MICTURITION URGENCY 32
944 MUSCLE ATROPHY 32
945 MUSCLE TWITCHING 32
946 NEUTROPHIL COUNT INCREASED 32
947 PANCREATIC DISORDER 32
948 POUCHITIS 32
949 SKIN HAEMORRHAGE 32
950 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 32
951 ABNORMAL LOSS OF WEIGHT 31
952 ABSCESS LIMB 31
953 ADVERSE REACTION 31
954 ANKLE FRACTURE 31
955 BLOOD CALCIUM INCREASED 31
956 BLOOD THYROID STIMULATING HORMONE INCREASED 31
957 BONE LESION 31
958 BREAST PAIN 31
959 BREATH SOUNDS ABNORMAL 31
960 CANCER PAIN 31
961 CHOKING SENSATION 31
962 DIVERTICULUM INTESTINAL 31
963 FOREIGN BODY IN THROAT 31
964 HEPATIC ENCEPHALOPATHY 31
965 INJECTION SITE RASH 31
966 PARKINSON^S DISEASE 31
967 PELVIC PAIN 31
968 PNEUMONIA VIRAL 31
969 POSTOPERATIVE WOUND INFECTION 31
970 RED CELL DISTRIBUTION WIDTH INCREASED 31
971 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 31
972 SUBDURAL HAEMATOMA 31
973 TENDONITIS 31
974 TOOTH LOSS 31
975 ACUTE MYELOID LEUKAEMIA 30
976 ATRIOVENTRICULAR BLOCK FIRST DEGREE 30
977 AUTOIMMUNE DISORDER 30
978 BLOOD GLUCOSE FLUCTUATION 30
979 CHAPPED LIPS 30
980 CORONARY ARTERY OCCLUSION 30
981 DEVICE RELATED SEPSIS 30
982 EAR DISCOMFORT 30
983 FEAR 30
984 FRACTURE 30
985 HYPERAESTHESIA 30
986 INJECTION SITE MASS 30
987 INTENTIONAL DRUG MISUSE 30
988 LACERATION 30
989 MALABSORPTION 30
990 METASTASES TO LYMPH NODES 30
991 MOOD SWINGS 30
992 OROPHARYNGEAL DISCOMFORT 30
993 PAROSMIA 30
994 PROTHROMBIN TIME PROLONGED 30
995 PURULENT DISCHARGE 30
996 SINUS BRADYCARDIA 30
997 SKIN ATROPHY 30
998 SQUAMOUS CELL CARCINOMA OF SKIN 30
999 THERAPEUTIC PRODUCT EFFECT DELAYED 30